Advertising Driven Press Release Distribution
Advertising Driven Press Release Distribution
The study projects the market to grow at a CAGR of 11.39% between 2022-2032 BIS Research, the global leader in providing market intelligence on deep technologies, has released its latest study titled Flow Cytometry in Oncology and Immunology Market – […]
Read More>>Sydney, 20 July 2022 – Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is lending its support to Glioblastoma (GBM) Awareness Day 2022 and remains firmly focused on developing a treatment that may help improve the […]
Read More>>The latest study from BIS Research on the acellular therapy market suggests a substantial increase in the adoption of cell-free therapy across different medical disciplines, such as oncology, neurology, and cardiology. The premium market intelligence by BIS Research also highlights […]
Read More>>The premium market intelligence report published by BIS Research on the title Global Oncology Precision Medicine Market highlights that the market is projected to reach $128.9 billion by 2031. The study also highlights that the market is set to witness […]
Read More>>Market Overview “The Global Precision Medicine Market is expected to grow at a CAGR of 9.50% during the forecasting period (2021-2028)”. Precision medicine is an advanced approach for patient care and treatment by selecting desired treatments based on a genetic understanding of […]
Read More>>Market Overview The “Global Oncology Nutrition Market” is expected to grow at a CAGR of 8.20% during the forecasting period (2020-2027). Cancer-affected people have a direct impact on their natural appetite and to avoid the risk of suffering from any other disorders […]
Read More>>This report aims to provide detailed insights into the global interventional oncology market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this […]
Read More>>The Fireside Chat will take place on Wednesday, February 10th at 2:00 pm Eastern Time. The live event will also be archived and available for replay. The Fireside Chat is open for all investors to access. “We are excited to […]
Read More>>Exton, PA: Acceletronics Inc., today announced its exclusive distribution agreement with Cablon Medical, The Netherlands, for their new CNERGY radiotherapy solutions. Total body radiation therapy can be a complex treatment for the end user. CNERGY TBI alleviates many of the […]
Read More>>Sydney, Australia and Los Angeles, California 21 July 2020 – Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, and ImaginAb, Inc., a company that harnesses the specificity of monoclonal antibodies, have entered into a collaboration agreement […]
Read More>>The Brave & Beautiful Blood Cancer Foundation announces its 1st annual Healthy Families Festival featuring a 1 Mile Warrior Walk in a Fight to End Blood Cancer The Brave & Beautiful Blood Cancer Foundation partners with The City of Las […]
Read More>>What the market looks like? Rising preference for minimally invasive procedures, increasing public-private funding and government support for cancer research, technological advancements in the field of interventional oncology, and increasing government investments and funding for interventional oncology and related cancer […]
Read More>>The growth of a interventional oncology market is primarily driven by the rising preference for minimally invasive procedures, expansion of the target patient population, increasing public-private funding and government support for cancer research, technological advancements in the field of interventional […]
Read More>>